The aim of this study was to define mechanisms involved in the luminal upta
ke of inorganic mercury in the kidney using isolated perfused straight (S-2
) segments of the proximal tubule. When mercuric conjugates of glutathione
(GSH), cysteinylglycine, or cysteine (containing Hg-203(2+)) were perfused
through the lumen, the rates of luminal disappearance flux (J(D)) of inorga
nic mercury were approximately 39, 53, and 102 fmol/min per mm, respectivel
y. Thus, the rates of luminal uptake of mercury are greater when the mercur
y is in the form of a mercuric conjugate of cysteine than in the form of a
mercuric conjugate of cysteinylglycine or GSH. Addition of acivicin to the
perfusate, to inhibit activity of the gamma-glutamyltransferase, caused sig
nificant reductions in the J(D) for mercury in tubules perfused with mercur
ic conjugates of GSH. Addition of cilastatin, an inhibitor of dehydropeptid
ase-1 (cysteinylglycinase) activity, caused significant reductions in the u
ptake of mercury in tubules perfused with mercuric conjugates of cysteinylg
lycine. These findings indicate that a significant amount of the luminal up
take of mercury, when mercuric conjugates of GSH are present in the lumen,
is dependent on the activity of both gamma-glutamyltransferase and cysteiny
lglycinase. Finally, the J(D) for mercury in tubules perfused with mercuric
conjugates of cysteine was reduced by approximately 50% when 3.0 mM L-lysi
ne or 5.0 mM cycloleucine was added to the perfusate. It is concluded that
these findings indicate that at least some of the luminal uptake of mercuri
c conjugates of cysteine occurs at the site of one or more amino acid trans
porters via a mechanism involving molecular homology.